Feed aggregator

Biotechs Share Promising Breast Cancer Data at San Antonio Symposium

Biospace news - Fri, 12/10/2021 - 02:00
The 2021 San Antonio Breast Cancer Symposium is meeting December 7–10 at the Henry B. Gonzalez Convention Center in San Antonio, Texas, and virtually.

Three More Biopharma Expansions to Round Out the Week

Biospace news - Fri, 12/10/2021 - 02:00
Innocoll Biotherapeutics, Genapsys, and Adicet Bio announced today their relocation and expansion plans.

Roche's Latest Checkpoint Target Shows Promise for Lung Cancer

Biospace news - Fri, 12/10/2021 - 02:00
Roche announced promising results from the Phase II CITYSCAPE study of tiragolumab plus Tecentriq compared to Tecentriq alone as a treatment for PD-L1-positive metastatic NSCLC.

ACT for ALS Passes House while BrainStorm Prepares Moves Ahead with NurOwn

Biospace news - Fri, 12/10/2021 - 02:00
​A U.S. Congress subcommittee unanimously approved the ACT for ALS bill in a decision that could soon pour massive funding into the search for treatment for this debilitating and deadly disease.

COVID-19 Has Brought out the Best – and Worst – in Humanity

Biospace news - Fri, 12/10/2021 - 02:00
A TikTok video went “viral” in November, claiming that vaccine regretters should take complex “detox” baths featuring ingredients such as borax.

Yale Team Unlocks Genetic Door to Deadly Brain Aneurysms

Biospace news - Fri, 12/10/2021 - 02:00
A team of Yale researchers has found a key to unlocking the deadly mystery of brain aneurysms in adults.

Research Roundup: Controlling Blood Glucose Levels Decreases Cancer Risk and More

Biospace news - Fri, 12/10/2021 - 02:00
Cancer cells, because of their high metabolism and rapid growth, use up a lot of energy, which is supplied in the body by glucose, or blood sugar.

BioSpace Movers & Shakers, Dec. 10

Biospace news - Fri, 12/10/2021 - 02:00
As the year comes to an end, biopharma and life sciences companies are strengthening their leadership teams and boards with the latest round of Movers & Shakers.

Decades-Old Stool Sample Provides New Insight on HIV Susceptibility

Biospace news - Fri, 12/10/2021 - 02:00
A new study conducted on a 35-year-old blood and stool sample provides new insights into HIV research and the role the gut microbiome may have played in infection among infected individuals.

Experimental mRNA Flu Vaccine Looks Good in the Interim, But Fails to Impress Investors

Biospace news - Fri, 12/10/2021 - 02:00
Shares of Moderna are down nearly 10% this morning despite the company posting positive interim results from an experimental seasonal flu vaccine.

Four Fresh-Faced Biopharmas Reel in Millions in Series A Funds

Biospace news - Thu, 12/09/2021 - 02:00
​The cash came rolling in for four biopharma companies Thursday morning, with collective Series A rounds totaling more than $125 million.

EUA of AstraZeneca's Pre-Exposure Therapy Offers Hope for Immunocompromised

Biospace news - Thu, 12/09/2021 - 02:00
The FDA has approved emergency use authorization for AstraZeneca's Evusheld cocktail as prophylaxis against COVID-19 infection in adults and adolescents aged at least 12 years.

Key Takeaways from Elizabeth Holmes' Seven-Day Testimony

Biospace news - Thu, 12/09/2021 - 02:00
​Throughout her defense, she cast blame for Theranos' troubles on her former partner and lover, Ramesh "Sunny" Balwani, as well as subordinates who she claimed misled her.

China Puts Renewed Focus on Monoclonal Antibodies in COVID-19 Fight

Biospace news - Thu, 12/09/2021 - 02:00
Researchers in China are busy developing several treatments, combining vaccines and drugs for COVID-19, as also working on monoclonal antibody treatments.

Reuters Investigation Points to J&J Coverup for Diabetes Drug Risk

Biospace news - Thu, 12/09/2021 - 02:00
Reuters alleges Johnson & Johnson knew of the ketoacidosis risk of its diabetes drug Invokana but covered it up.

After Setbacks, CymaBay Pushes Forward with Potential Liver Disease Treatment

Biospace news - Thu, 12/09/2021 - 02:00
The holds were lifted by the FDA in July of 2020, but the company’s timeline had been severely set back by the miscalculation.

Reata Stock Takes a Blow as FDA Panel Voted Down Alport Syndrome Drug

Biospace news - Thu, 12/09/2021 - 02:00
Shares of Reata Pharmaceuticals have plunged nearly 40% in premarket trading after an FDA advisory panel recommended against the approval of its Alport syndrome disease treatment, bardoxolone.

CSL and uniQure’s Hemophilia B Gene Therapy Hits the Mark

Biospace news - Thu, 12/09/2021 - 02:00
CSL Behring and uniQure announced that their etranacogene dezaparvovec hit the pre-specified primary endpoint in their Phase III clinical trial in severe to moderately severe hemophilia B.

New Study: Fat Cells Are a Reservoir for COVID-19 Infection

Biospace news - Thu, 12/09/2021 - 02:00
Researchers published a study proving that SARS-CoV-2 infects human adipose or fat tissue to multiply and elicit an inflammatory response corresponding with severe COVID-19.

Global Roundup: Cyxone's COVID Asset Fails to Distinguish Itself in Phase II

Biospace news - Thu, 12/09/2021 - 02:00
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.